Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Centella asiatica Nanoparticles as Potential Acetylcholinesterase Inhibitors for Cognitive Decline Therapy Using the Ellman Method: an In Vitro Study

Folia Medica Indonesiana · Vol. 60 No. 4 (2024) · hlm. 271–280

DOI
10.20473/fmi.v60i4.62182
ISSN
2355-8393, 2599-056X
Terbit
2024-12-11
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

According to the World Health Organization (2021), cognitive impairment affects 65,6 million elderly people worldwide. Decreased cognitive function in the elderly is caused by neurocognitive changes and inflammation in nerve cells that can interfere with quality of life. Pegagan extract is known to have neuroprotective potential through the active compounds contained in it. An effective drug delivery system is needed so that the active compounds of the drug act as neuroprotective agents through the apoptosis signal inhibition pathway that can cross the blood brain barier (BBB) at adequate concentrations to provide neuroactive effects that support the potential use of this extract as neurotherapy. In this case, pEG-400 was chosen as the drug delivery system. This research was conducted at Universitas Airlangga by covering several stages of testing, namely the GC-MS test to identify active compounds in pegagan extract, tryptamine, γ-sitosterol and β-sitosterol which play a role in improving cognitive function. Synthesis shows that the 1:100 formulation between pegagan extract and pEG-400 produces ideal-sized nanoparticles (5-7 nm), which are optimal for penetrating the BBB. PSA and SEM tests support these results by showing homogeneous particle morphology and consistent chemical composition. High in vitro Ellman's reagent inhibition test with 97.63% effectiveness indicates that the 1:100 formulation is effective as an acetylcholinesterase inhibitor. The 1:1 and 1:100 formulations are very effective in acting as acetylcholinesterase inhibitors. This study shows that the combination of pEG-400 and pegagan extract has great potential as an innovative pharmacological therapy for such cases, but further research is needed to ensure the right dosage and development of research results.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 103 tautan kepenulisan bersama · 20 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • University of Indonesia
  • State University of Malang
  • Tanjungpura University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sri Agus SudjarwoUniversitas Airlangga3
Aucky HintingUniversitas Airlangga3
Hamdani LunardhiUniversitas Airlangga2
Doddy Moesbadianto SoebadiUniversitas Airlangga2
Alis Nur DianaUniversitas Airlangga1
Sri PurwaningsihUniversitas Airlangga1
Reryd Arindany WiryawanAfiliasi tidak diketahui1
Maria Paulina Budyandini Dyah PramestiUniversitas Airlangga1
Hamdani LunardhiAfiliasi tidak diketahui1
Alivery Raihanada ArmandoUniversitas Airlangga1
Wihasto SuryaningtyasRumah Sakit Dokter Soetomo1
Candra Dwantara RamadhanRumah Sakit Dokter Soetomo1
Muhammad Fadhil KamaruddinUniversitas Airlangga1
Ramadhani Rizki ZamzamUniversitas Airlangga1
Evy WulandariUniversitas Airlangga1
Rahmawati RaharjoAfiliasi tidak diketahui1
Arifa MustikaUniversitas Airlangga1
Sandra Dewi SitaresmiUniversitas Airlangga1
Ninik DarsiniUniversitas Airlangga1
R. Haryanto AswinUniversitas Airlangga1
Umie LestariState University of Malang1
Gondo MastutikUniversitas Airlangga1
Alphania RahniayuUniversitas Airlangga1
Isnin Anang MarhanaUniversitas Airlangga1
Mochamad AminUniversitas Airlangga1
Heru Fajar TriantoTanjungpura University1
Rina YudiwatiUniversitas Airlangga1
Tita Rudini YassinUniversitas Airlangga1
Rina YaudiwatiUniversitas Airlangga1
Mohammad Ayodhia SoebadiUniversitas Airlangga1
Kristophorus Jonathan WibowoAfiliasi tidak diketahui1
Muhammad Hidayat Surya AtmajaAfiliasi tidak diketahui1
Supardi SupardiAfiliasi tidak diketahui1
Ria MargianaAfiliasi tidak diketahui1
Fatkhurrohmah Leo AmaliaAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Centella asiatica Nanoparticles as Potential Acetylcholinesterase Inhibitors for Cognitive Decline Therapy Using the Ellman Method: an In Vitro Study</dc:title><dc:creator>Nathania Nathania</dc:creator><dc:creator>Selvina Cindy Kusumaningrum</dc:creator><dc:creator>Reny I’tishom</dc:creator><dc:creator>Feranita Kumalasari</dc:creator><dc:creator>Ria Margiana</dc:creator><dc:subject>Centella asiatica</dc:subject><dc:subject>nanoparticles</dc:subject><dc:subject>acetylcholinesterase inhibitors</dc:subject><dc:subject>cognitive decline</dc:subject><dc:subject>neuroprotection</dc:subject><dc:subject>blood-brain barrier</dc:subject><dc:subject>polyethylene glycol 400</dc:subject><dc:subject>drug delivery systems</dc:subject><dc:subject>tryptamine</dc:subject><dc:subject>γ-sitosterol</dc:subject><dc:subject>β-sitosterol</dc:subject><dc:subject>Ellman's assay</dc:subject><dc:subject>Alzheimer's disease</dc:subject><dc:description xml:lang="en">According to the World Health Organization (2021), cognitive impairment affects 65,6 million elderly people worldwide. Decreased cognitive function in the elderly is caused by neurocognitive changes and inflammation in nerve cells that can interfere with quality of life. Pegagan extract is known to have neuroprotective potential through the active compounds contained in it. An effective drug delivery system is needed so that the active compounds of the drug act as neuroprotective agents through the apoptosis signal inhibition pathway that can cross the blood brain barier (BBB) at adequate concentrations to provide neuroactive effects that support the potential use of this extract as neurotherapy. In this case, pEG-400 was chosen as the drug delivery system. This research was conducted at Universitas Airlangga by covering several stages of testing, namely the GC-MS test to identify active compounds in pegagan extract, tryptamine, γ-sitosterol and β-sitosterol which play a role in improving cognitive function. Synthesis shows that the 1:100 formulation between pegagan extract and pEG-400 produces ideal-sized nanoparticles (5-7 nm), which are optimal for penetrating the BBB. PSA and SEM tests support these results by showing homogeneous particle morphology and consistent chemical composition. High in vitro Ellman's reagent inhibition test with 97.63% effectiveness indicates that the 1:100 formulation is effective as an acetylcholinesterase inhibitor. The 1:1 and 1:100 formulations are very effective in acting as acetylcholinesterase inhibitors. This study shows that the combination of pEG-400 and pegagan extract has great potential as an innovative pharmacological therapy for such cases, but further research is needed to ensure the right dosage and development of research results.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2024-12-11</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v60i4.62182</dc:identifier><dc:identifier>10.20473/fmi.v60i4.62182</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 60 No 4 (2024); 271-280</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/62182/30862</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>